Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112142617A details a novel oxidative carbonylation method for synthesizing alpha,beta-unsaturated alkynamides with high selectivity and recyclable catalysts.
Advanced synthesis of 5-oxo-tetrahydropyran-3-carboxylic ester via Pd-catalyzed carbonylation. Offers cost reduction in API manufacturing and scalable production.
Patent CN104109174B introduces a novel ligand for asymmetric methoxycarbonylation, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Novel palladium-catalyzed route for baloxavir intermediate. Safer, scalable, cost-effective manufacturing solution for global supply chains.
Novel patent CN110128347A enables high-purity indazole intermediate production with scalable carbonylation technology for reliable pharmaceutical supply chains.
Novel patent CN112624981B details a high-yield route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN116768709B reveals a green synthesis route for 2-hydroxystilbenes. Offers high purity, scalable manufacturing, and cost-effective supply chain solutions for global buyers.
Patent CN108003156A reveals mild double carbonylation. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN105037420A details mild Pd-catalyzed synthesis. Enables high-purity pharmaceutical intermediates with scalable cost reduction and supply reliability.
Patent CN102863399A details a mild carbonylation route for isatoic anhydrides, offering safer alternatives to phosgene for reliable pharmaceutical intermediate suppliers.
Patent CN110437069B details a continuous decarbonylation method for 2-fluoromalonic diesters, ensuring safer production and superior yields for API intermediates.
Novel nickel-catalyzed carbonylation method offers cost-effective gamma-oxoester production. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel Pd-catalyzed route eliminates toxic CO gas, ensuring high purity and safety for commercial scale-up of complex pharmaceutical intermediates.
Patent CN107556320A details Pd-catalyzed carbonylation for high-purity intermediates. Offers stable raw materials and scalable synthesis for global supply chain reliability.
Novel Pd-catalyzed route for penta-hepta-homopiperazinone derivatives offers high yield and mild conditions for scalable API intermediate production.
Patent CN104803905A reveals high-yield palladium catalysis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing globally.
Patent CN114163428B reveals a safe, one-pot copper-catalyzed route for Topramezone, eliminating high-pressure CO and reducing manufacturing costs significantly.
Novel palladium-catalyzed carbonylation patent offers cost-effective high-purity pharmaceutical intermediates with scalable supply chain reliability for global procurement teams.
Patent CN109761875B reveals a high-yield Rh-catalyzed method for indole-3-carboxamides, offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Patent CN108276334B enables efficient acridone synthesis. Reduces steps and improves atom economy for pharmaceutical intermediates manufacturing supply chains.